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Abstract
Diesel exhaust presents a community exposure hazard, but methods to measure internal exposure 
are lacking. We report results from a community-based study using 1-nitropyrene (1-NP) and its 
urinary metabolites as markers of exposure to traffic-related diesel particulate matter (DPM). The 
study participants were Tijuana, Mexico residents who commuted on foot into San Diego, 
California for work or school using the International San Ysidro Port of Entry, placing them within 
feet of idling traffic (referred to as border commuters). The comparison group (non-border 
commuters) was comprised of residents of south San Diego who did not commute into Mexico. 
Air concentration of 1-NP in fine particulate matter (PM2.5) was measured in personal samples 
from participants. Spot urine samples were analyzed for 1-NP urinary metabolites 8-hydroxy-1-
nitropyrene (8-OHNP) and 8-hydroxy-N-acetyl-1-aminopyrene (8-OHNAAP). Compared with 
non-border commuters, border commuters had two- to threefold higher mean urinary 
concentrations for unadjusted and creatinine-adjusted 8-OHNP and 8-OHNAAP. Urinary 8-
OHNAAP and the sum of 8-OHNP and 8-OHNAAP were both associated with personal exposure 
to 1-NP in the prior 24 h. These results suggest that 1-NP urinary metabolites reflect recent 
exposure to DPM-derived 1-NP in community settings and can be useful for exposure analysis.
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INTRODUCTION
Diesel exhaust (DE) is a complex mixture that includes both gas and particle phase 
components.1 Epidemiologic and toxicologic studies have demonstrated that exposure to 
ambient DE is associated with acute and chronic respiratory and cardiovascular adverse 
health effects and lung cancer. DE has been classified as carcinogenic to humans (group 1).2 
The chemical substances in DE that have been found to contribute to its carcinogenicity and 
mutagenicity include nitropolycyclic aromatic hydrocarbons (NPAHs).1 NPAHs are a group 
of organic compounds that originate directly from incomplete combustion such as from DE 
emissions, or are formed indirectly as a result of heterogeneous or gas-phase reactions of 
their parent compounds, PAHs, with atmospheric oxidants such as NOx and OH.3,4 NPAHs 
are often more toxic than their parent PAH compounds.5
The compound 1-nitropyrene (1-NP) is a four-ring NPAH that exists primarily in the 
particulate phase at ambient temperatures,6 and is one of the main contributors to the direct-
acting mutagenicity of NPAHs.7–9 1-NP is mostly emitted directly from combustion 
processes, although small amounts may be formed from secondary reactions.10 Diesel 
emissions are the major source of 1-NP, with small amounts emitted from other sources, 
including coal combustion, soy bean cooking oil, and gasoline vehicles.11,12 As 1-NP is 
greatly enriched in diesel emissions compared with other combustion sources, 1-NP in air 
has been used as a marker of exposure to diesel particulate matter (DPM).13–15
Urinary metabolites specific to 1-NP may be useful as biomarkers of exposure to DE. 
Metabolism of 1-NP has been studied in vitro in human and animal cell lines and in vivo in 
rats. Metabolism is reported to proceed via P450-mediated C-oxidation, acetylation, and 
nitroreduction.16–21 The major urinary metabolites that have been observed in rats and 
humans in vivo are hydroxy-1-nitropyrenes (OHNPs), hydroxy-N-acetyl-1-aminopyrenes 
(OHNAAPs), N-acetyl-1-aminopyrene, and 1-aminopyrene.22–27 Human studies have 
demonstrated that urinary metabolites of 1-NP are higher in participants with exposure to 
elevated levels of DPM.14,28–33 In studies that examined multiple urinary 1-NP metabolites, 
the most abundant isomers detected were 6- and 8-hydroxy-1-nitropyrene (8-OHNAAP) and 
6- and 8-OHNP.28,31
Although previous studies have assessed the utility of 1-NP and its metabolites as markers 
for occupational exposure to DPM,14,30,31 there are no community-based studies that have 
measured both personal exposure to 1-NP and urinary 1-NP metabolites. This study 
addresses the ability of these biomarkers to detect exposures to ambient concentrations of 
DE in a group of persons residing in Mexico and crossing the US–Mexico border 
northbound in the pedestrian lane at the San Ysidro Port of Entry (SYPOE), next to long 
lines of idling diesel buses. Urinary biomarker levels were compared with a control group 
not crossing the US–Mexico border.
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MATERIALS AND METHODS
Study Population
The study population was described in detail in our prior publication.34 In brief, two groups 
were recruited for participation in this study. One group (“border commuters”) had 
potentially high exposure to DE as a result of standing 20–200 min within feet of idling 
buses during their northbound pedestrian commute across the US–Mexico SYPOE. Border 
commuters lived in Tijuana, Mexico and crossed at the SYPOE on foot to work or go to 
school in San Diego, California. We also recruited a comparison group (“non-border 
commuters”) that we anticipated to have lower DE exposure. This group included 
participants who lived and worked or went to school in San Diego and did not cross into 
Mexico. All participants were self-reportedly free of any chronic lung, liver, and heart 
disease; all self-classified as Hispanic/Latino, non-smokers in a non-smoking home, and not 
occupationally exposed to DE. One participant was excluded from analysis as a result of 
being occupational exposed to DE. Sampling occurred between 30 March 2010 and 17 
December 2010. Approval was obtained by San Diego State University and University of 
Washington institutional review boards for all human participant data collection procedures. 
Further recruitment details, exclusion criteria, and descriptive statistics are described in 
detail elsewhere.34
Sample Collection
Forty-four participants were enrolled in the study (27 border commuters and 17 non-border 
commuters). Of the 44 participants, 28 (12 border commuters and 16 non-border 
commuters) were sampled one time and 16 (15 border commuters and 1 non-border 
commuter) were sampled more than once with the criterion that 3 weeks had passed since 
their last participation. As a result of repeat participation, there were a total of 73 border 
commuter events and 18 non-border commuter events (Table 1). Samples collected per event 
included a 24-h time activity diary, a questionnaire, a spot urine sample, and, on some 
participants, a personal air sample for 24 h to measure personal exposure to 1-NP. Urine 
samples were collected from participants immediately following the end of their 24-h study 
period. Participants were anticipated to have steady-state concentrations for urinary 
metabolites owing to consistent daily weekday routines; therefore, concentrations collected 
were assumed to be representative of their daily values. Urine was not successfully collected 
from five participants (all border commuters).
1-NP air concentrations were measured on a subset of subjects. Of the 91 participant events, 
71 (56 border commuter events and 15 non-border commuter events) had personal 24-h 
measurements of 1-NP (Table 1).
Details of 1-NP and urine sample collection have been described elsewhere.34 In brief, 1-NP 
was collected on a 37-mm PTFE Teflon filter with a 2 μm pore size (SKC, Eighty Four, PA, 
USA) using a fine particulate matter (PM2.5) impactor (BGI HPEM, Waltham, MA, USA 
and SKC PEM, Eighty Four, PA, USA) connected to a personal air sampling pump (AirChek 
XR5000; SKC) operated at 4 l/min. For personal 1-NP samples, impactors were placed near 
the participants’ breathing zone. Urine samples were collected in 500 ml polyethylene wide-
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mouth bottles (VWR 16129-040; Radnor, PA, USA) for men and commode specimen 
containers (VWR 15704-116) for women. Both urine and 1-NP samples were immediately 
placed on ice and transferred to the San Diego State University School of Public Health 
laboratory and stored at −20 °C in a freezer. Before freezing, urine samples provided by 
women were transferred to the Nalgene polyethylene 500 ml bottles. Before analysis, all 
samples were shipped overnight on dry ice to the University of Washington and stored at 
−20 °C.
Sample Extraction, Quantification, and Analysis
1-NP in filter samples.—1-NP in air was measured as described by Miller-Schulze et al.
13
 Sample extractions occurred in seven batches and each batch included two blank filters 
and two spiked filters to assess quality control. Extracts from all batches were quantified 
using two-dimensional high-performance liquid chromatography tandem mass spectrometry 
and were quantified in the same run to minimize between-day variability of the instrument. 
The average 1-NP concentration calculated to be present in the field blanks was 0.028 
pg/m3, with a standard deviation of 0.0071 pg/m3. The effective limit of quantification 
(LOQ) was set to (blank+2 SD)/square root of 2, resulting in an LOQ of 0.030 pg/m3. 
Concentrations below the LOQ were substituted with 0.030 pg/m3. The accuracy and 
precision of the extraction and two-dimensional high-performance liquid chromatography 
tandem mass spectrometry was 80 ± 12% of the expected values as determined by looking at 
concentrations of 1-NP in spiked (fortified) filters.
Urinary 1-NP metabolites.—Urinary 1-NP metabolites were measured using an high-
performance liquid chromatography tandem mass spectrometry method as described 
previously.31 Urine volumes collected ranged from 20 to 482 ml, with an average of 165 ml. 
Extractions were optimized for 100 ml of urine. Of the 91 urine samples, 25 had volumes < 
100 ml and thus were diluted with deionized water to bring the volume to 100 ml. The 1-NP 
metabolite concentrations (in pg metabolite per ml urine for a nominal 100 ml urine sample) 
calculated to be present in assay blanks were typically <0.02 pg/ml (calculated for a nominal 
100 ml urine sample). These levels of contamination, while clearly distinguishable from the 
chromatographic baseline, were typically observed at the approximate level of the lowest 
calibration standard. The LOQ for the assay was set to (blank+2 SD)/sqrt2; 8-OHNP = 0.011 
pg/ml and 8-OHNAAP = 0.014 pg/ml. These values were substituted for concentrations 
below the LOQ.
Fortified samples were prepared by spiking 100 ml deionized water with 25 ml of a standard 
solution containing 0.5 ng 8-OHNP and 1.0 ng 8-OHNAAP, along with the requisite 
deuterated internal standard spike analogous to that for the urine samples. The accuracy and 
precision of calculated concentrations of 1-NP metabolite species in the fortified samples 
were 8-OHNAAP 66 ± 6% and 8-OHNP 73 ± 6%.
Urinary creatinine levels were measured in the clinical laboratory at the University of 
Washington Medical Center using a colorimetric assay, and the creatinine measurements 
were used to adjust for diuresis. For each urine sample, 1 ml was held aside for this purpose, 
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except where the urine void volume was small and all the sample was used for the 1-NP 
metabolite analysis.
Statistical Analysis
The data set includes all samples for both 1-NP and its urinary metabolites, including the 
samples below the LOQ, which were substituted with (blank+2 SD)/sqrt2. Comparison of 
urinary concentrations between border commuters and non-border commuters was 
accomplished using a t-test. A multilevel linear regression model was performed on all study 
participants:
Ln(Personal exposure to 1 − NP)ij = β0 + β1 Ln(metabolite)ij + μi + eij
where i represents the participant, j represents a specific urine and filter sample pair, β0 is the 
intercept parameter, β1 is the slope estimate for the corresponding predictor variable (8-
OHNP, 8-OHNAAP, or 8-OHNP+8-OHNAAP), and μi+eij is the random part of the model 
with the following distributions: μi ~ N(0, γ2), eij ~ N(0, σ2)
The results of the multilevel linear regression model were used to obtain an estimate of what 
percentage change in personal exposure to 1-NP was associated with the percent change in 
urinary metabolites.
In addition, within the subgroup of border commuters, we explored the association between 
urinary 1-NP metabolites and several predictor variables related to time spent commuting, 
time spent in proximity to roadways, and time spent at the border crossing. A list of the 
covariates used in the regression analysis can be found in Table 2. All the travel times are 
estimated from participants’ time activity diary. All the covariates were continuous except 
for season, which was dichotomized into Spring/Summer (1 March to 31 August) and 
Autumn/Winter (1 September to 28 February). Season was tested as an interaction term for 
other predictor variables in the regression models. There were 47 border commuter events in 
the Autumn/Winter and 21 in the Spring/Summer.
We controlled for the effect of repeat participants in the regression analysis to minimize the 
possibility of any potential effect of more frequent repeated sampling of border commuters 
versus non-border commuters. Natural log transformations were used for all continuous 
variables. The Mann–Whitney U-test and all linear regression models used an α of P < 0.05 
level of significance. Data analysis was performed using STATA/IC ver. 13.1(StataCorp LP, 
College Station, TX, USA).
RESULTS
Table 3 summarizes the descriptive statistics for the two 1-NP urinary metabolites and their 
sum for border commuter events and non-border commuter events, for both creatinine-
adjusted and -unadjusted concentrations. The metabolite 8-OHNP was the most commonly 
detected in urine samples. For unadjusted 8-OHNP, 1/68 (1.5%) of border commuter events 
and 2/18 (11%) non-border commuter events were below the LOQ. For unadjusted 8-
OHNAAP, 37/68 (54%) of border commuter events and 12/18 (66%) of non-border 
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commuter events were below the LOQ. Urinary 1-NP metabolite-unadjusted 8-OHNP 
concentrations were significantly higher for border commuters than non-border commuters, 
as were the sum of the metabolites (Table 3). Border commuters had approximately twofold 
higher levels of 8-OHNP compared with non-border commuters (mean concentration for 
unadjusted 0.076 vs 0.033 pg/ml; mean concentration for creatinine-adjusted 0.092 vs 0.042 
pg/mg creatinine) (Table 3). Compared with non-border commuters, border commuters had 
threefold higher levels of unadjusted 8-OHNAAP (mean concentration 0.067 vs 0.021 pg/
ml), and twofold higher levels of creatinine-adjusted 8-OHNAAP (0.065 vs 0.033 pg/mg 
creatinine) (Table 3). Summed mean metabolite concentrations were also 2-3 fold higher in 
border commuters compared to non-border commuters (Table 3).
Table 4 shows the linear regression results exploring the association between urinary 1-NP 
metabolites and personal exposure to 1-NP. The unadjusted models provide similar effect 
estimates for each metabolite and the sum of the metabolites estimating a 14% increase in 1-
NP exposures for each 10% increase in 8-OHNP (P = 0.3), a 20% increase in 1-NP 
exposures for each 10% increase in 8-OHNAAP (P = 0.02), and a 16% increase in 1-NP 
exposures for each 10% increase in the sum of the metabolites (P = 0.01). Effect estimates 
were similar for the creatinine-adjusted models, and were modestly attenuated when data 
below the LOD were excluded.
Using multilevel linear regression modeling, for the subgroup of border commuters, we also 
examined the univariate predictors of urinary 1-NP metabolites listed in Table 2. Age and 
gender were not included in these models. In our sensitivity analysis age, as a continuous 
variable, had a small, nonsignificant effect on the effect estimate. Similarly, including gender 
in the models did not substantially change the effect estimate. Overall, these analyses did not 
indicate that the travel-related measures of exposure listed in Table 2 were informative 
predictors of urinary metabolite levels, with most effect estimates being small with wide 
confidence intervals encompassing zero. The time spent outdoors in Mexico and the United 
States was fairly equivalent (median: 216 min Mexico and 247 min United States). However, 
total time spent outdoors, including border commute, was small compared with the time 
spent at home (median: 67%). Border commuters spent a median of 60 min commuting the 
border per day. Season was the only significant predictor in the model for the unadjusted 8-
OHNAAP metabolite (β1 = 0.049; 95% confidence interval: 0.004–0.094), a finding that is 
consistent with our observation that border commuters’ personal exposures to 1-NP were 
60% higher in Winter vs Summer.35
DISCUSSION
This is the first study that compares urinary 1-NP metabolites with personal exposure to 1-
NP to examine community exposure to DPM. In our study, we observed that border 
commuters had higher concentrations of two 1-NP metabolites, 8-OHNP, and 8-OHNAAP, 
as compared with non-border commuters, consistent with our previous report from the same 
sample that border commuters had higher personal 1-NP exposures compared with non-
border commuters.34 Median concentrations for personal 1-NP were 6.5-fold higher for 
border commuters (median, interquartile range: 0.96, 0.33–1.87 pg/m3) compared with non-
border commuters (median, interquartile range: 0.15 pg/m3, 0.05–0.30 pg/m3).34 In addition, 
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higher urinary 1-NP metabolite concentrations were associated with higher personal 1-NP 
exposures: increases of 10% in urinary concentrations of 8-OHNP, 8-OHNAAP, or the sum 
of the two metabolites were associated with increases in personal 1-NP exposures over the 
prior 24 h of 14%, 20%, and 16%, respectively. However, the confidence intervals on these 
effect estimates were broad and the regression models explained only a small proportion of 
the variability in the relationship between 1-NP measured in the previous 24 h and the 
urinary metabolites.
Similarly, in his study of taxi drivers in Shenyang, China, Miller-Schulze et al.31 also 
reported positive associations between urinary 1-NP metabolites and personal 1-NP 
exposures. However, the urinary concentrations of the 1-NP metabolites were not strongly 
predictive of the recent air exposure levels. There are several factors that could attenuate this 
relationship. For compounds that are eliminated relatively rapidly, a single spot urine sample 
may not be well correlated with longer-term exposures. Another potential source of 
variability that we were unable to address relates to inter-individual differences in 
metabolism that could attenuate the relationships between 1-NP and urinary biomarker 
levels.
The 8-OHNP metabolite levels we observed were at least 10-fold lower compared with those 
reported previously for highly exposed occupational cohorts,14,31 and ~ 5-fold lower 
compared with the one previous report of a convenience sample of non-occupationally 
exposed participants (university students and faculty) from Kanazawa, Japan.28 
Nevertheless, we were able to distinguish differences in DPM exposure in the range of 
exposures taking place in the community.
A limitation of this study is that we were not able to quantify how much the border commute 
contributed to overall DPM exposure. The border commuters may have had additional 
exposure to DPM in Mexico, thus we cannot attribute the increase in 1-NP metabolites 
unequivocally to the exposure at the SYPOE. Additionally, participants who resided in 
Tijuana but who did not cross the border would have helped to resolve the contribution to 1-
NP exposure associated with living in Tijuana from that associated with the border 
commute. Logistical considerations made this approach not feasible for the study reported 
here. In conclusion, we have demonstrated that urinary 1-NP metabolites were detectable in 
residents of the US–Mexico border communities of Tijuana, Mexico and San Diego, CA, 
and urinary concentrations were significantly higher in spot samples from the cohort of 
border commuters relative to a control group of non-border commuters, and were positively 
associated with measured personal exposures to 1-NP over the 24 h before urine collection. 
Overall, given the important adverse health impacts of community exposures to DE, a highly 
specific marker for DPM may prove useful to improve assessment of DE exposures. In spite 
of recent improvement in diesel engine technology that have markedly reduced DE 
emissions, including 1-NP, it is significant that 1-NP and its urinary metabolites were, 
nevertheless, readily detectable in this study of participants exposed to ambient 
concentrations of DE within their communities. With rising concerns about community level 
exposure to goods movement facilities, such as ports and freight rail yards, 1-NP and the 
corresponding urinary metabolites show promise as suitable markers of exposure to DE. 
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However, further studies are needed to better characterize sources of variability in the 
relationship between DE exposure and biomarker response.
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Table 4.
Univariate analysis using multilevel linear regression modeling.a
Model parameter nb β1 CI P-valuec n (%<LOQ)d
8-OHNP
 Unadjusted 68, 31 1.4 -1.2, 4.0 0.30 1 (1.5)
 Creatinine adjusted 49, 27 1.3 -1.3, 3.9 0.31 1 (2)
8-OHNAAP
 Unadjusted 68, 31 1.9 0.35, 3.5 0.02 26 (45)
 Creatinine adjusted 49, 27 1.9 -0.26, 4.0 0.08 7 (22)
8-OHNP+8-OHNAAPP
 Unadjusted 68, 31 1.8 0.41, 3.1 0.01 3 (4.5)
 Creatinine adjusted 49, 27 1.6 -0.002, 3.3 0.05 3 (6.5)
Abbreviations: CI, confidence interval; LOQ, limit of quantification; 8-OHNAAP, 8-hydroxy-N-acetyl-1-aminopyrene; 8-OHNP, 8-hydroxy-1-
nitropyrene; 1-NP, 1-nitropyrene.
a
To examine association between urinary 1-NP metabolites and personal exposure to 1-NP (pg/m3) for all study participants. Accounted for repeat 
samples in the modeling.
bNumber of border commuter events, number of participants.
cP < 0.05 in bold.
d
n < LOQ, number of urine samples below limit of quantification. Samples below and above LOQ were included in analysis.
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